The evidence of acupressure is limited in the management of dysmenorrhea. To evaluate the efficacy of acupressure in the treatment of primary dysmenorrhea based on randomized controlled trials (RCTs), we searched MEDLINE, the Chinese Biomedical Database 
Introduction
Primary dysmenorrhea is defined as the occurrence of painful menstrual cramps of uterine origin in women during menstruation without any evident pathology [1] . It is characterized by crampy pelvic pain with pain radiating to the lower back or anterior thigh, nausea, vomiting, diarrhoea, headache, fatigue, nervousness, and dizziness beginning shortly before or at the onset of menses and lasting one to three days [2] . The prevalence of dysmenorrhea is highest in adolescent women, with estimates ranging from 40 to 50 percent [3] . It is the leading cause of recurrent short-term school absenteeism in adolescent girls in the United States [3, 4] . Most adolescents self-medicate with over-the-counter medicines, and few consult a physician about dysmenorrheal [5, 6] .
Therapies for primary dysmenorrhea include pharmacological, nonpharmacological, and surgical approaches; however, many of the standard treatments have not been well studied. The recommendations reflect a balance between the available evidence and an assessment of benefit, harm, and cost [7] . Nonsteroidal anti-inflammatory drugs (NSAIDs) are the best-established initial therapy for dysmenorrheal [8] . They have a direct analgesic effect through inhibition of prostaglandin synthesis, and they decrease the volume of menstrual flow. Surgical approaches may be used, but the evidence for nerve interruption in the management of dysmenorrhea is limited [9] . Complementary and alternative medicines, including supplements, herbal remedies, physical treatments, are choices of these patients [8, [10] [11] [12] [13] . As a noninvasive technique, acupressure relieves pain by pressing the special acupoints with fingers or thumbs [14] . However, there is no convincing evidence in the treatment of primary dysmenorrhea. It is necessary to evaluate the efficacy of body acupressure in the treatment of primary dysmenorrhea when compared with a placebo, no treatment, or conventional medical treatment based on randomized controlled trials (RCTs).
Methods

Search Strategy.
The literature search was performed on MEDLINE, the Chinese Biomedical Database (CBM), and [23] . Sequence generation, allocation concealment, blinding (or masking), incomplete data assessment, selective outcome reporting, and other sources of bias were assessed with three potential responses: yes, no, and unclear (Table 1) . Disagreements between review authors were resolved by discussion or with a third author (Bi-meng Zhang).
Statistical analysis was performed with RevMan 5.1 software. For dichotomous data, results for each study were expressed as Peto odds ratios (OR) with corresponding 95% confidence intervals (CI) using the Mantel-Haenszel method. We expressed continuous data as weighted mean differences (WMD) with 95% CI or as standardized weighted mean differences (SMD) if outcomes were conceptually the same but measured in different ways in the different trials.
If there were "multi-arm" studies, for example, there are two acupressure groups with a common control group or two control intervention groups such as a placebo group and a standard treatment group, and data from both treatment arms were combined into one group. For studies with a placebo control and no treatment control group, the shared intervention was divided evenly between groups as described in the Cochrane Handbook [23] .
We included a more formal chi 2 test. A low value (or a large chi 2 statistic relative to its degree of freedom) provided evidence of heterogeneity of intervention effects (variation in effect estimates beyond chance). We measured inconsistency across trials in the meta-analysis using the 2 statistic described in the Cochrane Handbook for Systematic Reviews of Interventions [23] . We planned to investigate potential biases of publication using the funnel plot or other analytical methods [24] . In the presence of significant heterogeneity, we aimed to examine the causes by subgroup analysis and also sensitivity analysis. If subgroup analysis failed to explain the heterogeneity, data were analyzed with the random-effects model.
Results
Description of Included Studies.
The search retrieved 224 potentially relevant records, including 86 trials from PubMed, 125 from CBM, 2 from CENTRAL, and 11 trials from manual search. 177 records were excluded by screening the titles and abstracts, including 8 duplicates. The remaining 47 full-text articles were retrieved for additional scrutiny, of which 39 proved ineligible because of no mention of randomization or quasirandomised trials. Thus 8 trials were included in the current review. The types of control interventions, and data extraction for these 8 studies are depicted in Table 2 .
All the 8 trials used a parallel design, including 800 patients [15] [16] [17] [18] [19] [20] [21] [22] . Six trials had two study groups [15, 16, 18, 19, 21, 22] . One trials had three groups [20] and one trials had four arms [17] . Comparative and control groups varied. Six trials used no treatment controls, including placebo, rest, and waiting control [15] [16] [17] [18] [19] 22] . Two are single-blind clinical trials, in which participants were treated with placebo acupressure [18, 19] . Comparisons with medication using Ibuprofen were used in two trials [20, 21] .
The research location of 3 trials was in China (two in Taiwan, one in Hong Kong, and none in Chinese Mainland), one in the USA, and four in Iran. Among these trials, the largest sample size was 216 [20] , the smallest sample size was 30 [19] , and the average sample size was 100. The data in each trial were analyzed individually with special software (RevMan 5.1).
Fixed sets of acupressure points were used in all trials. Patients received acupressure for one menstrual cycle in two studies [19, 20] , two menstrual cycles in three studies [16, 18, 21] , and three menstrual cycles in three studies [15, 17, 22] . VAS scales were used in six trials to assess pain relief [16] [17] [18] [19] [20] 22 ]. An assessment of pain and other menstrual symptoms Test for overall effect: Z = 6.21 (P < 0.00001) Heterogeneity: 2 = 0.07, df = 1 (P = 0.79); I 2 = 0%
Test for overall effect:Z = 6.24 (P < 0.00001) Heterogeneity: 2 = 0.67, df = 1 (P = 0.41); I 2 = 0%
Test for overall effect: Z = 6.31 (P < 0.00001)
Heterogeneity: 2 = 6.09, df = 1 (P = 0.01); I 2 = 84%
Test for overall effect: Z = 5.84 (P < 0.00001) was undertaken in the remaining two studies with Andersch and Milsom scale [15] , and Descriptive Numeric Rating Scale of Pain Intensity and Dysmenorrhea Symptom Intensity and Distress Inventory [21] .
Risk of Bias in Included
Studies. See Figures 1 and 2 for a graphical summary of the risk of bias assessments of the included studies made by authors based on the risk of bias domains. No trial was at a low risk of bias on all domains. Using the Cochrane criteria, we rate the risk of bias. Only one of 8 studies had a low risk of selection bias, detection bias, and attrition bias [15] , and the sequence was generated by means of a table of random numbers. We found high risks of bias in the included studies to be failure to describe or use appropriate adequate generation of randomisation sequence (7/8), concealment of allocation (8/8) , and lack of effective blinding procedures (observer (7/8); patient (8/8); care provider (8/8)). We acknowledge that it is difficult to blind the patient and impossible to blind the care provider in acupressure treatments. Test for overall effect: Z = 0.61 (P = 0.54)
Effects of
Test for overall effect: Z = 1.12 (P = 0.26)
Test for overall effect: Z = 1.36 (P = 0.17)
Test for overall effect: Z = 3.15 (P = 0.002)
Test for overall effect: Z = 3.78 (P = 0.0002)
Test for overall effect: Z = 4.61 (P < 0.00001)
Heterogeneity: 2 = 1.14, df = 2 (P = 0.57); = 0% 
Heterogeneity
Discussion
There are only eight trials assessing the role of acupressure in the management of primary dysmenorrhoea. Eight studies and data from 800 participants were included in the systematic review. Six studies examined the efficacy of acupressure using placebo controlled designs. There was some limited evidence of acupressure showing a benefit in relation to the primary outcomes of pain relief (VAS) and reduced menstrual symptoms. There was an improvement in pain relief compared with placebo or rest control (WMD − There are three other reviews of acupuncture-related therapies for primary dysmenorrhoea [25] [26] [27] . Cho and Hwang included 4 trials, suggesting that acupressure alleviates menstrual pain [25] . Yang et al. identified 3 trials of body acupressure and 4 trials of auricular acupressure, which were excluded in our review [26] . Smith CA found that there was an improvement in pain relief from acupressure compared with a placebo control (WMD −0.99, 95% CI −1.48 to −0.49), and in one trial acupressure reduced menstrual symptoms compared with a placebo control (WMD −0.58, 95% CI −1.06 to −0.10) [27] . Cho and Hwang and Yang et al. both included other modalities of TCM and included trials for which we were unable to ascertain the randomisation details [25, 26] . Both reviews found promising evidence for the use of acupuncture to treat primary dysmenorrhoea compared with pharmacological medicine or Chinese herbal medicine. These findings from the three reviews were influenced by the methodological flaws of the trials.
We noted low quality evidence of all the included eight studies suggesting the limited benefit should be interpreted with caution. The completeness and applicability of the evidence is limited as from the 8 included trials, only one reported meaningful data and seven were at a high or unclear risk of bias on all domains.
Because of low methodologic quality and small sample size, there is no convincing evidence for acupuncture in the treatment of primary dysmenorrhea. Well-designed RCTs with rigorous methods of randomisation, and adequately concealed allocation are needed.
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